In April 2026, the Division of Corporation Finance of the U.S. Securities and Exchange Commission shortened the minimum ...
On October 28, 2026, GT Metabolicâ„¢ Solutions, a pioneer in the medical device field and the first to receive FDA De Novo ...
On October 22, 2026, Gilead Sciences, a biopharmaceutical company pursuing breakthroughs in medicine, announced that it has entered into a definitive agreement to acquire an oral IL-23R ...
On October 27, 2026, US WorldMeds, a specialty pharmaceutical company, and Orbus Therapeutics, a privately held pharmaceutical company developing investigational eflornithine for rare and serious ...
On October 27, 2026, Guidewire, a cloud platform for P&C insurers, announced that it entered into a definitive agreement to acquire hyperexponential, a London-based agentic platform provider of ...
On October 19, 2026, the Federal Trade Commission (FTC), together with the attorneys general of twelve states, filed a complaint in the Northern District of California seeking a permanent injunction ...
On October 28, partner Jodi Daniel was featured on the Surescripts podcast There’s a Better Way: Smart Talk on Healthcare and Technology. In the episode, Jodi discusses her background as a federal ...
On October 19, 2026, the Federal Trade Commission (FTC) announced that it had entered a proposed consent order resolving its concerns over Publicis’s $2.2 billion acquisition of LiveRamp. The case is ...
Thinking of creating a non-fungible token (NFT) marketplace? You're not alone. Global NFT transactions have risen from $40.96 million in 2018 to around $25 billion in 2021. Organizations from the NBA ...
Wilson Sonsini is proud to sponsor the 2026 ChIPs Global Summit in Los Angeles. The event brings together leaders across technology, law, policy, and innovation for two days of connection, ...
On October 29, 2026, Bambusa Therapeutics, a Boston-based clinical-stage company developing next-generation, long-acting precision bispecific antibodies for immunology and inflammation, announced the ...